American Society of Health-System Pharmacists

7272 Wisconsin Ave
Bethesda, MD 20814

American Society of Health-System Pharmacists News

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS: Widespread Unavailability of Critical Medications Jeopardizes Patient Care in U.S. Hospitals

ASHP (American Society of Health-System Pharmacists), the 45,000-member national association representing pharmacists who serve as patient care providers in acute and ambulatory care settings, is calling for swift action from policymakers to address the persistent shortages of critical medications in hospitals and health systems. Read More »

AMERICAN SOCIETY OF HEALTH -SYSTEM PHARMACIST: Provider Status Bill Receives Public Support at House Hearing on Opioids

A hearing of the House Energy and Commerce Committee’s health subcommittee on the opioid epidemic, Rep. Cathy McMorris Rodgers (R-Wash.) discussed the pharmacist’s role in delivering patient care to Medicare beneficiaries and noted her support for legislation that allows pharmacists to care for patients in certain underserved areas. Specifically, she mentioned the benefits of H.R. 592, the Pharmacy and Medically Underserved Areas Enhancement Act, and submitted a letter of support from the Washington Pharmacy Association. Read More »

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACIST: ASHP Virtual House of Delegates Approves New Policies for 2018

ASHP’s virtual House of Delegates recently approved professional policies on gene therapy, unit dose packaging availability, and drug dosing in conditions that modify pharmacokinetics or pharmacodynamics, among other topics. Following discussion in the House of Delegates community on ASHP Connect, delegates voted online during the week of March 16–23. Read More »

ASHP discusses efforts to educate professionals on non-controlled drug abuse

The American Society of Health-System Professionals (ASHP) recently announced that Michael Cohen, operations officer for the investigations branch of the Department of Health and Human Services (HHS) Office of Inspector General (OIG) in Washington, D.C., believes clinicians need to not just look at opioids but also at non-controlled drugs when trying to understand drug abuse. Read More »